CoChat

Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota

Open access
MetaHIT consortium, Forslund, Kristoffer, Hildebrand, Falk, Nielsen, Trine, Falony, Gwen, Le Chatelier, Emmanuelle, Sunagawa, Shinichi, Prifti, Edi, Vieira-Silva, Sara, Gudmundsdottir, Valborg, Krogh Pedersen, Helle, Arumugam, Manimozhiyan, Kristiansen, Karsten, Yvonne Voigt, Anita, Vestergaard, Henrik, Hercog, Rajna, Igor Costea, Paul, Roat Kultima, Jens, Li, Junhua, Jørgensen, Torben, Levenez, Florence, Dore, Joël, Bjørn Nielsen, H., Brunak, Søren, Raes, Jeroen, Hansen, Torben, Wang, Jun, Dusko Ehrlich, S., Bork, Peer, Pedersen, Oluf · 2015 · Nature

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

In recent years, several associations between common chronic human disorders and altered gut microbiome composition and function have been reported. In most of these reports, treatment regimens were not controlled for and conclusions could thus be confounded by the effects of various drugs on the microbiota, which may obscure microbial causes, protective factors or diagnostically relevant signals. Our study addresses disease and drug signatures in the human gut microbiome of type 2 diabetes mellitus (T2D). Two previous quantitative gut metagenomics studies of T2D patients that were unstratified for treatment yielded divergent conclusions regarding its associated gut microbial dysbiosis. Here we show, using 784 available human gut metagenomes, how antidiabetic medication confounds these results, and analyse in detail the effects of the most widely used antidiabetic drug metformin. We provide support for microbial mediation of the therapeutic effects of metformin through short-chain fatty acid production, as well as for potential microbiota-mediated mechanisms behind known intestinal adverse effects in the form of a relative increase in abundance of Escherichia species. Controlling for metformin treatment, we report a unified signature of gut microbiome shifts in T2D with a depletion of butyrate-producing taxa. These in turn cause functional microbiome shifts, in part alleviated by metformin-induced changes. Overall, the present study emphasizes the need to disentangle gut microbiota signatures of specific human diseases from those of medication.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nature15766

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Research works printed but not linked: 1

  1. Madden, T. in The NCBI Handbook [Internet]. (eds, McEntyre J. & Ostell J. ) Ch. 16 (National Center for Biotechnology Information, 2002) http://www.ncbi.nlm.nih.gov/books/NBK21097/

Cited by

See all 2,116

Metadata

Authors
MetaHIT consortium, Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., Prifti, E., Vieira-Silva, S., Gudmundsdottir, V., Krogh Pedersen, H., Arumugam, M., Kristiansen, K., Yvonne Voigt, A., Vestergaard, H., Hercog, R., Igor Costea, P., Roat Kultima, J., Li, J., Jørgensen, T., Levenez, F., Dore, J., Bjørn Nielsen, H., Brunak, S., Raes, J., Hansen, T., Wang, J., Dusko Ehrlich, S., Bork, P., & Pedersen, O.
Affiliations
  • Vrije Universiteit Brussel (BE)
  • University of Copenhagen (DK)
  • Rega Institute for Medical Research (BE)
  • European Molecular Biology Laboratory (DE)
  • Microbiologie de l’alimentation au service de la santé (FR)
  • BGI Group (China) (CN)
Corresponding author
Pedersen, Oluf
Venue
Nature
Published
2015-12-02
Volume
528
Issue
7581
Pages
262-266
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2188930066
Cited by
2,116
References
49
Citations by year
2026: 113 · 2025: 167 · 2024: 212 · 2023: 194 · 2022: 253 · 2021: 270 · 2020: 256 · 2019: 185 · 2018: 197 · 2017: 150 · 2016: 112 · 2015: 3
FWCI
66.83
Type
journal article
Language
en
Update notices
erratum (2017-05-04)
Open access
Licence
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Socio-Environmental Systems Modeling (acceptedVersion)
  • HAL (submittedVersion, cc-by-nc-nd)
  • HAL (submittedVersion)
  • Research Portal (King's College London) (submittedVersion, other-oa)
  • Lirias (KU Leuven) (submittedVersion, other-oa)
  • RePEc: Research Papers in Economics (submittedVersion)
  • MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
  • VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
  • Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
  • VUBIR (Vrije Universiteit Brussel) (submittedVersion)
Funders
  • Innovationsfonden
  • European Molecular Biology Laboratory
  • European Commission (600375, 2007–2013, FP7 2007-2013, HORIZON2020, FP7/2007, 305312, 201052, 261376)
  • Agence Nationale de la Recherche (ANR-11-DPBS-0001)
  • Lundbeckfonden
  • Novo Nordisk
  • Göteborgs Universitet
  • Copenhagen Graduate School for Nanoscience and Nanotechnology
  • Novo Nordisk Foundation Center for Basic Metabolic Research
  • H. Lundbeck A/S
  • FP7 Ideas: European Research Council (268985)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
type 2 diabetes, gut microbiota, metformin, antidiabetic drugs, dysbiosis, confounding by treatment, short-chain fatty acids, butyrate, Escherichia, metagenome-wide association study
MeSH terms
Gastrointestinal Microbiome, Diabetes Mellitus, Type 2, Female, Humans, Hypoglycemic Agents, Male, Metformin, RNA, Ribosomal, 16S, Biodiversity, Metagenome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. https://app.cochat.ai/papers/10.1038/nature15766
The paper
MetaHIT consortium, Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., Prifti, E., Vieira-Silva, S., Gudmundsdottir, V., Krogh Pedersen, H., Arumugam, M., Kristiansen, K., Yvonne Voigt, A., Vestergaard, H., Hercog, R., Igor Costea, P., Roat Kultima, J., Li, J., . . . Pedersen, O. (2015). Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature. https://doi.org/10.1038/nature15766

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.